Fenbendazole Market Latest Trends, Future Strategies And Growth Forecast Till 2030
Fenbendazole is a benzimidazole-class broad-spectrum anthelmintic. Fenbendazole is a drug that is used to treat gastrointestinal parasites in animals' stomachs and intestines. Roundworms, hookworms, whipworms, some tapeworms, and parasites known as strongyles and Strongyloides are all susceptible to it. Fenbendazole is an efficient dewormer because it prevents worms from growing and reproducing, therefore controlling and killing them.
Market Driver For Fenbendazole
Increasing R&D initiatives to improve the efficacy of fenbendazole in treating various diseases in animals and people is a major factor driving the Fenbendazole Market forward. For example, researchers from India's National Centre for Human Genome Studies and Research (NCHGSR) announced in August 2018 that fenbendazole has the potential to be an effective anti-cancer agent. Fenbendazole can also be used to overcome drug resistance, which is common in cancer treatment.
To investigate this, researchers used fenbendazole to treat human non-small cell lung cancer cells, which resulted in tumor cell death. Because it can take a long time and money to turn a promising chemical into an approved drug, repurposing veterinary drugs to treat diseases in humans can be beneficial and has shown promising outcomes, and it is predicted to save money without the need to develop new drugs.
Furthermore, the Fenbendazole Market is Predicted To Rise due to the approval of novel fenbendazole medications. For example, the United States Food and Drug Administration (USFDA) approved Merck Animal Health's Safe-Guard AquaSol, a fenbendazole oral suspension used in the treatment and control of adult Ascaridia galli in broiler chickens and Heterakis gallinarum in breeding chickens via drinking water, in January 2018. Safe-Guard AquaSol is made using cutting-edge wet-milling technology, which results in a highly stable suspension that may be used again.
Market Restraint For Fenbendazole
Drug resistance to fenbendazole as a result of incorrect or excessive drug use in horses is anticipated to stifle the Fenbendazole Market growth. According to the National Equine Health Survey (NEHS) 2016, increased usage of fenbendazole medications in horses in the United States has resulted in widespread drug resistance in these animals. The use of fenbendazole medications in horses for the treatment of encysted tiny red worms promotes gut infection, according to the same source.
Comments
Post a Comment